유세포 분석에 의한 각종 칸디다 균종의 Rhodamine 6G 축적 분석 = Species-Specific Differences in Rhodamine 6G Accumulation of Candida Isolates Detected by Flow Cytometric Analysis

다국어 초록 (Multilingual Abstract)

Background : Fluorescent dye Rhodamine 6G (R6G) is a substrate of multidrug resistance pumps and its accumulation is reduced in some azole-resistant Candida isolates with the upregulation of multidrug efflux transporter genes. Despite reports on species-specific differences in azole susceptibility
in various Candida species, only a few studies have been reported on the R6G accumulation among clinical isolates of Candida species. In this study, we compared R6G accumulation between six different Candida species.
Methods : The intracellular accumulation of R6G and minimal inhibitory concentrations (MICs) of three triazole agents were investigated in 48 strains of six Candida species (14 C. albicans, 9 C. tropicalis, 8 C. glabrata, 8 C. krusei, 7 C. parapsilosis, and 2 C.haemulonii ). R6G accumulation was measured by using flow cytometry and the geometric mean of the fluorescence intensity (GMF) was used to compare the accumulation between the Candida isolates.
Results : The GMF values for the C. tropicalis, C. albicans, C. krusei, C. parapsilosis, and C. glabrata isolates were 167.3±18.5, 126.9±6.6, 88.5±18.5, 50.8±7.0, and 38.1±3.9, respectively. C. glabrata had a significantly lower mean GMF than all the other Candida species (P<0.05). While
some Candida strains with trailing growth phenomenon and increased fluconazole MIC did not have a reduced GMF, three Candida strains with increased MICs to all three triazole agents had a reduced GMF.
Conclusions : This study found species-specific differences in R6G accumulation in Candida. In addition, the intracellular R6G accumulation can be used to investigate the drug efflux mechanism in azole-resistant Candida strains.

국문 초록 (Abstract)

배경 : 형광물질인 rhodamine 6G (R6G)는 칸디다의 다약제
내성 펌프를 통해 균 밖으로 배출되는데, 다약제 내성 유출 유전
자가 과발현된 azole 내성 칸디다 균주에서 R6G의 세포내 축적
이 감소됨이 밝혀졌다. 칸디다의 azole 약제에 대한 감수성 정도
는 균종에 따라 서로 다름이 관찰되고 있는데, 서로 다른 칸디다
균종 간의 세포내 R6G 축적을 비교한 연구는 아직 시행된 바가
없다. 본 연구에서는 6종의 칸디다 균종을 대상으로 세포내 R6G
축적양을 측정하여 비교하여 보았다.
방법 : 칸디다 임상균주 및 표준균주 48주(Candida albicans
14주, Candida tropicalis 9주, Candida glabrata 8주, Candida
krusei 8주, Candida parapsilosis 7주 및 Candida haemulonii
2주)를 대상으로 하였다. 3가지 azole 항진균제(fluconazole,
itraconazole, voriconazole)에 대한 감수성 검사는
CLSI M27-A2의 broth microdilution법을 이용하여 minimal
inhibitory concentration (MIC)를 측정하였고, 칸디다 균
주의 세포내 R6G 축적 정도는 FACscan flow cytometer (BD
biosciences, USA)를 이용하여 geometric mean of fluorescence
intensity (GMF)를 측정하였다.
결과 : 세포내 R6G 축적을 측정하여 얻은 GMF의 평균은 균
종별로 C. tropicalis, C. albicans, C. krusei 및 C. parapsilosis에서
각각 167.3±18.5, 126.9±6.6, 88.5±18.5 및 50.8±
7.0순이었고, 가장 낮은 GMF를 보인 균종은 C. glabrata로서
(평균 38.1±3.9) 다른 균종에 비해 의의 있게 낮았다(P<0.05).
Trailing성장을 보인 5주와 fluconazole에서만 약제의존성 내
성(MIC 16-32 μg/mL)을 보이는 2주에서는 GMF의 감소가 관
찰되지 않은 반면, 세 가지 azole 항진균제 모두에 대한 MIC가
증가된 4주 중 3주(C. glabrata 2주 및 C. parapsilosis 1주)에
서 낮은 GMF가 관찰되어 다약제 유출에 의한 내성기전이 시사
되었다.
결론 : 6종의 칸디다를 대상으로 세포내 R6G 축적량을 측정
한 결과, GMF의 평균값은 다른 칸디다 균종에 비해 C. glabrata에서
낮게 측정되어 칸디다 균종에 따라 R6G 축적량에 차이
가 있음을 알 수 있었다. 또한, R6G의 축적 검사는 azole 계열
132 문창진∙신종희∙김다운 외 5인
항진균제에 내성을 보이는 칸디다 균주에서 다약제 약물 유출에
의한 내성기전을 조사하는데도 이용될 수 있으리라 생각된다.

참고문헌 (Reference)

• 1 우준희, "백혈구의 포도구균 탐식 측정-유체세포측정법과면역형광현미경측정의비교 -" 14 : 35-40, 1992
• 2 Rodero L, "Transient fungemia caused by an amphotericin B-resistant isolate of Candida haemulonii" 40 : 2266-2269, 2002
• 3 Sanglard D, "The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents" 43 : 2753-2765, 1999
• 4 Banerjee SN, "Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System" 91 : S86-S89, 1991
• 5 Maesaki S, "Rhodamine 6G efflux for the detection of CDR1-overexpressing azole-resistant Candida albicans strains" 44 : 27-31, 1999
• 6 Sanglard D, "Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences" 2 : 73-85, 2002
• 7 Clinical and Laboratory Standards Institute, "Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard-third edition. M27-A2. Wayne, PA: Clinical and Laboratory Standards Institute"
• 8 이지연, "RPMI 배지 및 RPMI-2% Glucose 배지를 이용한 Candida albicans의 Fluconazole 감수성 검사" 대한진단검사의학회 22 (22): 188-195, 2002
• 9 Sanglard D, "Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters" 39 : 2378-2386, 1995
• 10 Brun S, "Mechanisms of azole resistance in petite mutants of Candida glabrata" 48 : 1788-1796, 2004
• 11 Sanguinetti M, "Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance" 49 : 668-679, 2005
• 12 Vandeputte P, "Mechanisms of azole resistance in a clinical isolate of Candida tropicalis" 49 : 4608-4615, 2005
• 13 Izumikawa K, "Function of Candida glabrata ABC transporter gene, PDH1" 20 : 249-261, 2003
• 14 Guinea J, "Fluconazole resistance mechanisms in Candida krusei: the contribution of efflux-pumps" 44 : 575-578, 2006
• 15 Barchiesi F, "Experimental induction of fluconazole resistance in Candida tropicalis ATCC 750" 44 : 1578-1584, 2000
• 16 Sanglard D, "Current understanding of the modes of action of and resistance mechanisms to conventional and emerging antifungal agents for treatment of Candida infections, in Candida and Candidiasis" ASM press 349-383, 2002
• 17 Shin JH, "Changes in karyotype and azole susceptibility of sequential bloodstream isolates from patients with Candida glabrata candidemia" 45 : 2385-2391, 2007
• 18 이지연, "Candida 균종의 Fluconazole 감수성 검사를 위한 Spectrophotometric Broth Microdilution법의 평가" 대한진단검사의학회 22 (22): 253-259, 2002
• 19 Tsai HF, "Candida glabrata PDR1, a transcriptional regulator of a pleiotropic drug resistance network, mediates azole resistance in clinical isolates and petite mutants" 50 : 1384-1392, 2006
• 20 Shin JH, "Biofilm production by isolates of Candida species recovered from nonneutropenic patients: comparison of bloodstream isolates with isolates from other sources" 40 : 1244-1248, 2002
• 21 Lee W, "Antifungal susceptibility testing of Candida species by flow cytometry" 14 : 21-26, 1999
• 22 Ostrosky-Zeichner L, "Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States" 47 : 3149-3154, 2003